Zydus Lifesciences jumps after its arm receives tentative approval from USFDA for Roflumilast Tablets
Zydus Lifesciences is currently trading at Rs. 416.30, up by 4.90 points or 1.19% from its previous closing of Rs. 411.40 on the BSE. The scrip opened at Rs. 411.05 and has touched a high and low of Rs. 416.90 and Rs. 409.00 respectively. So far 9982 shares were traded on the counter. The BSE … Read more



